N04.5 Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis

Name of the Condition

• Nephrotic Syndrome with Diffuse Mesangiocapillary Glomerulonephritis
• ICD-10 Code: N04.5

Summary

Nephrotic syndrome with diffuse mesangiocapillary glomerulonephritis is a kidney disorder characterized by significant protein loss in the urine (proteinuria), low blood protein levels (hypoalbuminemia), high cholesterol (hyperlipidemia), and swelling (edema). The condition involves diffuse mesangiocapillary glomerulonephritis, a specific type of glomerular disease where the kidney's filtering units (glomeruli) show thickening of the glomerular basement membrane and mesangial expansion, impairing filtration and leading to protein leakage.

Causes

The condition is typically caused by diffuse mesangiocapillary glomerulonephritis, which may be primary (idiopathic) or secondary to systemic diseases such as infections (e.g., hepatitis B/C), autoimmune disorders (e.g., lupus), or malignancies. The underlying mechanism involves immune complex deposition or complement activation, leading to glomerular damage.

Risk Factors

• Genetic predisposition to glomerular diseases
• Systemic infections (e.g., hepatitis B/C, malaria)
• Autoimmune conditions (e.g., lupus, IgA nephropathy)
• Certain malignancies (e.g., lymphoma)
• Prior kidney disease or injury

Symptoms

• Severe swelling (edema), especially around the eyes, feet, and ankles
• Foamy urine due to excess protein
• Unexplained weight gain from fluid retention
• Fatigue and loss of appetite
• High cholesterol levels

Diagnosis

Diagnosis involves urine tests to detect proteinuria, blood tests to assess kidney function and albumin levels, and a kidney biopsy to confirm diffuse mesangiocapillary glomerulonephritis. Imaging studies or additional tests may be used to evaluate underlying causes, such as infections or autoimmune disorders.

Treatment Options

Treatment focuses on managing symptoms and addressing the underlying cause. This may include medications to reduce proteinuria (e.g., ACE inhibitors, ARBs), immunosuppressants for autoimmune-related cases, and lifestyle modifications (e.g., low-sodium diet, fluid restriction). In severe cases, dialysis or kidney transplantation may be necessary.

Prognosis and Follow-Up

Prognosis varies depending on the underlying cause and response to treatment. Some patients may achieve remission with therapy, while others may progress to chronic kidney disease. Regular follow-up with kidney function monitoring, blood pressure management, and medication adherence is essential to slow disease progression.

Complications

• Chronic kidney disease or kidney failure
• Blood clots (thromboembolism) due to protein loss
• Infections from immunosuppressive therapy
• Malnutrition or vitamin deficiencies
• Cardiovascular disease from prolonged hyperlipidemia

Lifestyle & Prevention

• Maintain a low-sodium, balanced diet to reduce edema
• Stay hydrated and limit fluid intake as advised
• Avoid nephrotoxic medications (e.g., NSAIDs)
• Manage underlying conditions (e.g., infections, autoimmune disorders)
• Regular exercise and weight management to support overall health

When to Seek Professional Help

Seek immediate medical attention if you experience severe swelling, sudden weight gain, reduced urine output, or signs of infection (e.g., fever, chills). Contact your healthcare provider for persistent symptoms like fatigue, foamy urine, or unexplained weight gain.

Tips for Medical Coders

Document the presence of diffuse mesangiocapillary glomerulonephritis and its association with nephrotic syndrome. Ensure clinical documentation supports the diagnosis, including biopsy findings or relevant lab results. Code N04.5 is specific to this condition and should not be used for other nephrotic syndrome subtypes. Verify that the underlying cause (if secondary) is appropriately coded separately if applicable.